Insider activity at Galecto, Inc. has been all selling for a year now: about $23,000 from three sellers, and zero buyers at market prices.
That's worth context: executives sell for plenty of routine reasons, from scheduled trading plans to tax bills. Buying is the rarer, more telling signal.
No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Schambye Hans T. | CEO | Sell | 700 | $21.38 | $15K | SEC |
| Jan 6, 2026 | Winslow Garrett | Executive Officer | Sell | 255 | $21.38 | $5K | SEC |
| Jan 6, 2026 | Firmani Lori | CFO | Sell | 135 | $21.41 | $3K | SEC |
| Jul 8, 2025 | Schambye Hans T. | CEO | Sell | 735 | $3.38 | $2K | SEC |
| Jul 8, 2025 | Winslow Garrett | Executive Officer | Sell | 260 | $3.39 | $881 | SEC |
| Jul 8, 2025 | Firmani Lori | CFO | Sell | 147 | $3.39 | $498 | SEC |
| Jan 7, 2025 | Winslow Garrett | Executive Officer | Sell | 471 | $5.60 | $3K | SEC |
| Jan 7, 2025 | Firmani Lori | CFO | Sell | 261 | $5.63 | $1K | SEC |
| Jan 7, 2025 | Schambye Hans T. | CEO | Sell | 1,341 | $5.60 | $8K | SEC |
| Aug 17, 2023 | OrbiMed Advisors Israel II Ltd | 10% Owner | Sell | 535,534 | $0.75 | $402K | SEC |
| Aug 17, 2023 | OrbiMed Advisors Israel II Ltd | 10% Owner | Sell | 38,327 | $0.75 | $29K | SEC |
| Aug 17, 2023 | OrbiMed Advisors Israel II Ltd | 10% Owner | Sell | 248,819 | $0.75 | $187K | SEC |
| Aug 2, 2023 | OrbiMed Capital GP VII LLC | 10% Owner | Sell | 26,622 | $3.00 | $80K | SEC |
| Aug 2, 2023 | OrbiMed Capital GP VII LLC | 10% Owner | Sell | 29,700 | $3.00 | $89K | SEC |
| Aug 2, 2023 | OrbiMed Capital GP VII LLC | 10% Owner | Sell | 153,078 | $3.00 | $459K | SEC |
In the last 12 months Galecto, Inc. insiders made open-market purchases worth about $0 and sales worth about $23,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in GLTO was filed on 2026-01-06.
No congressional trades in GLTO were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).